NM_020661.4(AICDA):c.369C>T (p.Pro123=) AND Hyper-IgM syndrome type 2
- Germline classification:
- Benign (1 submission)
- Last evaluated:
- Jan 25, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000960538.9
Allele description [Variation Report for NM_020661.4(AICDA):c.369C>T (p.Pro123=)]
NM_020661.4(AICDA):c.369C>T (p.Pro123=)
Condition(s)
Assertion and evidence details
Last Updated: Sep 29, 2024